Connection

QIANG TONG to Immunotherapy

This is a "connection" page, showing publications QIANG TONG has written about Immunotherapy.
Connection Strength

1.250
  1. A size-switchable nanocluster remodels the immunosuppressive microenvironment of tumor and tumor-draining lymph nodes for improved cancer immunotherapy. Biomaterials. 2025 Apr; 315:122910.
    View in: PubMed
    Score: 0.610
  2. Tumor pH-triggered PEG detachable nanoparticles for TLR7/8 agonist delivery to improve cancer immunotherapy. Biomater Sci. 2025 May 13; 13(10):2794-2805.
    View in: PubMed
    Score: 0.158
  3. Phagocytosis-Activating Nanocomplex Orchestrates Macrophage-Mediated Cancer Immunotherapy. Adv Mater. 2025 Jul; 37(28):e2500982.
    View in: PubMed
    Score: 0.158
  4. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. ACS Appl Mater Interfaces. 2024 May 22; 16(20):25665-25675.
    View in: PubMed
    Score: 0.148
  5. A Tumor-Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer. Small. 2021 07; 17(29):e2101208.
    View in: PubMed
    Score: 0.121
  6. Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy. Small. 2020 11; 16(46):e2004240.
    View in: PubMed
    Score: 0.029
  7. Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy. Nano Lett. 2019 08 14; 19(8):5356-5365.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.